Details for New Drug Application (NDA): 086505
✉ Email this page to a colleague
NDA 086505 describes HYPAQUE-76, which is a drug marketed by Ge Healthcare and is included in one NDA. Additional details are available on the HYPAQUE-76 profile page.
The generic ingredient in HYPAQUE-76 is diatrizoate meglumine; diatrizoate sodium. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
The generic ingredient in HYPAQUE-76 is diatrizoate meglumine; diatrizoate sodium. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
Summary for 086505
| Tradename: | HYPAQUE-76 |
| Applicant: | Ge Healthcare |
| Ingredient: | diatrizoate meglumine; diatrizoate sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 66%;10% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
